Report #2897291

Received May 20, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Pruritus

Symptom narrative

itching all over; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of generalized pruritus in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced generalized pruritus (Verbatim: itching all over). The outcome of the generalized pruritus was not reported. It was unknown if the reporter considered the generalized pruritus to be related to Shingrix. It was unknown if the company considered the generalized pruritus to be related to Shingrix. Additional Information: GSK Receipt Date: 14-MAY-2026 This case was reported by a patient via interactive digital media. The patient asked whether this was an allergic reaction. The batch number was not provided and a request for this information has been made.